KRAS Mutations and Prognostic Implications in Appendiceal Cancers | Caris Life Sciences
Home / Research / Publications / KRAS Mutations and Prognostic Implications in Appendiceal Cancers

Publications

KRAS Mutations and Prognostic Implications in Appendiceal Cancers

Introduction:

  • Despite shared embryonic origin, appendiceal cancers (AC) have distinct clinical and molecular features compared to colorectal cancers (CRC).
  • Detection of mutant KRAS has been associated with worse survival in CRC, whereas in AC the prognostic significance of mutant KRAS (55-65% prevalence) has yet to be characterized.
Download Publication
Learn More
Name(Required)